ÀÖ²¥´«Ã½

ÀÖ²¥´«Ã½ Members

Membership & Community

As a ÀÖ²¥´«Ã½ member, you’re part of a strong network of clinicians representing every profession and experience level in chest medicine. With us, you can develop personal and professional connections, cultivate your leadership skills, advocate for policies that improve access to health, and advance your career.

JOIN TODAY ABOUT MEMBERSHIP »

Advertisement

 

See what's happening

John R. Addrizzo, MD, FCCP, and Doreen Addrizzo-Harris, MD, FCCP

Honoring a legacy, empowering the future

A new ÀÖ²¥´«Ã½ Physician® article highlights the John R. Addrizzo, MD, FCCP, Endowed Research Grant in Sarcoidosis, a transformative and permanent fund dedicated to advancing research in sarcoidosis.


Headshot of Neil Freedman, MD, FCCP

Opportunity, leadership, and the mindset for change

In his latest President's Column, ÀÖ²¥´«Ã½ President Neil Freedman, MD, FCCP, reflects on the essence of leadership, mentorship, and the future of chest medicine. "I am a product of ÀÖ²¥´«Ã½â€™s leadership and mentorship, and I credit a large part of my personal and professional success to the organization."


A person in white gloves draws a corticosteroid from a vial into a syringe

Advancing postarrest care in the ICU

A new Critical Care Commentary article from the ÀÖ²¥´«Ã½ Physician publication highlights new evidence suggesting prophylactic antibiotics and biomarkers like neuron-specific enolase may help improve prevention and prognostication of cardiac arrest.

Conversation starters: Topics you want to discuss

CT (Computed tomography) scanner in hospital laboratory

Seeing the target, missing the risk? Radiation safety in advanced bronchoscopy

While patient exposure receives most of the attention when it comes to radiation risk, careful consideration must be given to the proceduralists and staff who are in the room day after day. In a new ÀÖ²¥´«Ã½ Physician article, members of the Interventional Procedures Section discuss steps toward safer practice, including basic radiation safety programs and standardizing how radiation is measured and reported.


Someone wearing blue gloves holds pills labeled

Positive results from TETON-1 trial introduce potential new therapy for IPF

Positive results from the TETON trials and expanding treatment options are encouraging for pulmonologists who are used to working with a limited tool kit for slowing disease progression in their patients with idiopathic pulmonary fibrosis (IPF). In a new ÀÖ²¥´«Ã½ Physician article, members of the Interstitial Lung Disease Section review treprostinil as a potential therapy for IPF.


Illustration of immune checkpoint inhibitors

Ventilatory management of immune checkpoint inhibitor pneumonitis

As immune checkpoint inhibitor (ICI) use continues to expand, prospective data on phenotype-guided management and extracorporeal membrane oxygenation selection criteria are urgently needed. In a new ÀÖ²¥´«Ã½ Physician article, members of the Mechanical Ventilation and Airways Management Section discuss current management strategies for ICI pneumonitis.

Twitter icon

Join the conversation on social media and connect with members of the ÀÖ²¥´«Ã½ community.

Advance your career. Become an FCCP.

When you become an FCCP (Fellow of the ÀÖ²¥´«Ã½), you play an active role in advancing the field of chest medicine while enjoying the prestige of being associated with a distinctive group of chest medicine professionals.


“I have found being an FCCP to be rewarding on a personal level, as well as a professional level. It has provided me with connections to colleagues nationally and internationally, and it has opened the door to leadership opportunities.â€

– Thomas Van der Kloot, MD, FCCP


FIND OUT MORE

Close

Advertisement